Date | Insider | Price | Amount |
---|---|---|---|
3-14-2024 Insider Buy |
Michael Snavely Chief Executive Officer |
$9.04 CAGR » |
$22,600.00 2,500 shares |
8-22-2019 Insider Buy |
Randall Crowder Chief Operating Officer |
$1.26 CAGR » |
$24,971.96 19,860 shares |
8-21-2019 Insider Buy |
Randall Crowder Chief Operating Officer |
$1.30 CAGR » |
$24,950.46 19,203 shares |
8-20-2019 Insider Buy |
Lori Tauber Marcus Director |
$1.23 CAGR » |
$1,230.00 1,000 shares |
Also See: Institutional Holders of PHUN
Also See: SEC filings
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 03/15/2024 | |
End date: | 05/02/2024 | |
Start price/share: | $10.59 | |
End price/share: | $6.65 | |
Dividends collected/share: | $0.00 | |
Total return: | -37.20% | |
Annualized Gain: | -282.91% | |
Starting investment: | $10,000.00 | |
Ending investment: | $6,280.00 | |
Years: | 0.13 |
Phunware Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent Phunware insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding PHUN
Free PHUN Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Other companies seeing insider buying close in time to when the Phunware Insider Buying occurred are:
Arrowhead Pharmaceuticals Insider Buying |